Financial Performance - Net profit attributable to shareholders for Q1 2024 was CNY 19,301,064.44, representing a significant increase of 56.68% year-over-year[11]. - Operating revenue for Q1 2024 was CNY 233,233,842.40, a decrease of 0.34% compared to the same period last year[11]. - The company reported a 62.55% increase in operating profit, amounting to CNY 25,135,948.18, driven by improved gross margins[13]. - Total operating revenue for Q1 2024 was CNY 233,233,842.40, a slight decrease from CNY 234,034,475.01 in Q1 2023[37]. - Net profit for Q1 2024 increased to CNY 19,301,064.44, compared to CNY 12,318,895.10 in Q1 2023, reflecting a growth of approximately 56.7%[38]. - Earnings per share for Q1 2024 was CNY 0.09, up from CNY 0.07 in Q1 2023, indicating improved profitability on a per-share basis[38]. - Operating profit for Q1 2024 was ¥14,388,351.01, compared to ¥7,769,636.19 in Q1 2023, indicating a significant increase of approximately 84.5%[40]. - Net profit for Q1 2024 was ¥11,371,858.05, up from ¥6,544,016.42 in Q1 2023, reflecting an increase of about 73.5%[40]. - Total comprehensive income for Q1 2024 was ¥11,371,858.05, compared to ¥6,544,016.42 in Q1 2023, marking an increase of approximately 73.5%[41]. Cash Flow - The net cash flow from operating activities surged to CNY 27,752,034.71, marking a remarkable increase of 299.93% year-over-year[11]. - Cash flow from operating activities in Q1 2024 was ¥27,752,034.71, a substantial increase from ¥6,939,253.11 in Q1 2023[42]. - Cash inflow from operating activities in Q1 2024 was ¥267,239,193.91, compared to ¥249,396,639.10 in Q1 2023, representing an increase of about 7.1%[42]. - The net cash flow from financing activities in Q1 2024 was ¥0.00, compared to ¥117,678,125.00 in Q1 2023, reflecting a change in financing strategy[43]. - The net cash flow from operating activities was $12,895,232.46, an increase from $6,417,985.26[45]. - The total cash inflow from investing activities amounted to $23,260,952.84, compared to $375.90 in the previous period[45]. - The net cash outflow from investing activities was $15,764,097.23, up from $681,187.46[45]. - The cash and cash equivalents at the end of the period were $133,702,096.59, down from $166,357,686.80[45]. - The net increase in cash and cash equivalents was a decrease of $2,879,245.06, compared to an increase of $123,859,021.59 previously[45]. Assets and Liabilities - Total assets as of March 31, 2024, reached CNY 655,393,109.34, a slight increase of 0.30% compared to the end of 2023[11]. - The company's total liabilities to assets ratio decreased to 16.83% for the consolidated financials, down from 19.58% at the end of 2023[11]. - Total liabilities decreased to CNY 146,523,483.10 from CNY 156,848,478.64, showing a reduction in financial obligations[36]. - Current liabilities totaled ¥105,682,202.82, down from ¥123,527,702.85, reflecting a decrease of about 14.5%[32]. - Total liabilities decreased to ¥110,283,168.28 from ¥127,939,468.25, a reduction of approximately 13.9%[33]. - Non-current assets increased to ¥237,748,259.55 from ¥228,656,206.75, showing a growth of approximately 4.8%[32]. - The company's retained earnings rose to ¥188,847,161.33 from ¥169,546,096.89, an increase of about 11.4%[33]. - The total equity attributable to shareholders increased to ¥545,109,941.06 from ¥525,490,976.38, reflecting a growth of approximately 3.7%[33]. Shareholder Information - The total number of shares outstanding is 205,445,536, with 152,337,903 shares (74.15%) subject to restrictions[18]. - The largest shareholder, CHINA EGG PRODUCTS ApS, holds 135,188,506 shares, representing 65.80% of total shares[19]. - Liu Wen, a board member and general manager, owns 10,758,692 shares, accounting for 5.2368% of total shares[20]. - The company has 3,493 common shareholders[18]. - A commitment was made by China Egg Products ApS to extend the lock-up period for its pre-IPO restricted shares by 12 months until January 17, 2025[26]. - There are no pledges or judicial freezes on shares held by shareholders with more than 5% ownership[22]. Litigation and Claims - The company reported a total of 3,149,553.00 yuan in litigation claims, which is 0.58% of the net assets at the end of the reporting period[25]. - The company has no major litigation or arbitration matters during the reporting period[25]. Expenses and Investments - Sales expenses rose by 38.58% to CNY 6,619,301.70, reflecting increased marketing and promotional efforts[13]. - The company reported a significant reduction in financial expenses, with a net financial cost of CNY -435,165.54 compared to CNY 90,569.59 in the previous year[37]. - The company is focusing on research and development, with R&D expenses amounting to CNY 3,963,799.42 in Q1 2024, down from CNY 4,275,291.56 in Q1 2023[37]. - Research and development expenses for Q1 2024 were ¥3,963,443.65, down from ¥4,274,935.79 in Q1 2023, indicating a reduction of about 7.3%[40]. - Total cash outflow from investing activities in Q1 2024 was ¥41,527,262.52, significantly higher than ¥2,149,082.84 in Q1 2023, indicating increased investment activity[43].
欧福蛋业(839371) - 2024 Q1 - 季度财报